RU94017352A - Method of treatment of oncological patients after gastroenteric surgery - Google Patents
Method of treatment of oncological patients after gastroenteric surgeryInfo
- Publication number
- RU94017352A RU94017352A RU94017352/14A RU94017352A RU94017352A RU 94017352 A RU94017352 A RU 94017352A RU 94017352/14 A RU94017352/14 A RU 94017352/14A RU 94017352 A RU94017352 A RU 94017352A RU 94017352 A RU94017352 A RU 94017352A
- Authority
- RU
- Russia
- Prior art keywords
- enriched
- treatment
- nutrient
- surgery
- gastroenteric
- Prior art date
Links
Abstract
FIELD: medicine, oncology. SUBSTANCE: method involves the use of nutrient solutions enriched with proteolytic enzyme preparations. Additionally, nutrient mixtures can be enriched with carotinoid licopin. Nutrient solutions based on standard nutrient mixtures were administrated by intragastral gavage. EFFECT: enhanced effectiveness of treatment, decreased normalization period.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU94017352/14A RU94017352A (en) | 1994-05-11 | 1994-05-11 | Method of treatment of oncological patients after gastroenteric surgery |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU94017352/14A RU94017352A (en) | 1994-05-11 | 1994-05-11 | Method of treatment of oncological patients after gastroenteric surgery |
Publications (1)
Publication Number | Publication Date |
---|---|
RU94017352A true RU94017352A (en) | 1996-07-27 |
Family
ID=48447626
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU94017352/14A RU94017352A (en) | 1994-05-11 | 1994-05-11 | Method of treatment of oncological patients after gastroenteric surgery |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU94017352A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2651458C2 (en) * | 2013-03-15 | 2018-04-19 | Апталис Фарма Лтд. | Composition containing digestive enzymes and nutrients suitable for enteral administration |
US10184121B2 (en) | 2013-06-28 | 2019-01-22 | Allergan Pharmaceuticals International Limited | Methods for removing viral contaminants from pancreatic extracts |
US10206882B2 (en) | 2007-02-20 | 2019-02-19 | Allergan Pharmaceuticals International Limited | Stable digestive enzyme compositions |
US10993996B2 (en) | 2013-08-09 | 2021-05-04 | Allergan Pharmaceuticals International Limited | Digestive enzyme composition suitable for enteral administration |
US11364205B2 (en) | 2010-10-01 | 2022-06-21 | Societe Des Produits Nestle S.A. | Stable low digestive enzyme content formulation |
-
1994
- 1994-05-11 RU RU94017352/14A patent/RU94017352A/en unknown
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10206882B2 (en) | 2007-02-20 | 2019-02-19 | Allergan Pharmaceuticals International Limited | Stable digestive enzyme compositions |
US11364205B2 (en) | 2010-10-01 | 2022-06-21 | Societe Des Produits Nestle S.A. | Stable low digestive enzyme content formulation |
RU2651458C2 (en) * | 2013-03-15 | 2018-04-19 | Апталис Фарма Лтд. | Composition containing digestive enzymes and nutrients suitable for enteral administration |
US10184121B2 (en) | 2013-06-28 | 2019-01-22 | Allergan Pharmaceuticals International Limited | Methods for removing viral contaminants from pancreatic extracts |
US10993996B2 (en) | 2013-08-09 | 2021-05-04 | Allergan Pharmaceuticals International Limited | Digestive enzyme composition suitable for enteral administration |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1105818T1 (en) | USES OF ET743 IN THE THERAPEUTIC TREATMENT OF CANCER | |
EP0696456A3 (en) | Combination of necrosis inducing substances with substances which are activated by necrosis for the selective treatment of tumours and or inflammatory diseases | |
PL335370A1 (en) | Orally administered preparation for preventing and treating bacterial infections caused by helicobacter sp. | |
AU2002352187A1 (en) | Use of laminarin in the treatment of cancer as well as bacterial, viral and fungal infections | |
EP1706423B8 (en) | Therapeutic and diagnostic anti-hsp 70 antibodies | |
TNSN04217A1 (en) | Use of docetaxel/doxorubicin/cyclophosphamide in adjuvant therapy of breast and ovarian cancer | |
RU94017352A (en) | Method of treatment of oncological patients after gastroenteric surgery | |
NO20016004D0 (en) | Composition comprising alkaline sphingomyelinase for use as a dietary, nutritional supplement or pharmaceutical product | |
AU1976183A (en) | N-(2-amino-3,5-dibromobenzyl)- trans-4-amino-cyclohexanol derivatives | |
DE3764532D1 (en) | PRODUCT FOR RADIOSENSIBILIZATION OF BIOLOGICAL TISSUES IN RADIOTHERAPY. | |
WO2004010934A3 (en) | Methods for the use of neurotoxin in the treatment of urologic disorders | |
ATE269065T1 (en) | TREATMENT OF DIGESTIVE DISORDERS | |
PH23658A (en) | Improved method of treating tumors with autologous lymphokine activated killer,interleukin-2 and an ornithine decarboxylase inhibitor | |
RU95104771A (en) | Method of treating exacerbating chronic parodontites | |
NO20020751L (en) | Chemically stabilized chlorite solutions for the treatment of cancer and other diseases | |
RU2149041C1 (en) | Method for rendering rehabilitative services to patients radically operated on the occasion of stomach carcinoma and possessing postresection disorders | |
RU94039944A (en) | Acid-milk product for treating allergy | |
SU1183116A1 (en) | Method of treatment of insufficiency of cholesecretion | |
RU94041253A (en) | Method for treating combined allergic lesions of skin and gastrointestinal tract in children | |
RU94022334A (en) | Method of treatment and prophylaxis of invasion diseases | |
UA43117A (en) | method for treatment of inflammatory diseases of prostate | |
RU94036142A (en) | Method of tumor treatment | |
RU94039553A (en) | Agent for chronic prostatitis treatment | |
UA30769C2 (en) | METHOD OF TREATMENT OF ONCOLOGICAL DISEASES | |
UA31004A (en) | METHOD OF PREVENTION AND TREATMENT OF NEPHROLYTHIA |